Groowe Groowe / Newsroom / AXSM
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

AXSM News

Axsome Therapeutics, Inc

Non-Postoperative Pain Management Outlook in Major Markets, 2026-2036 | Industry Poised for Growth as Non-Opioid Therapies and Advanced Drug Delivery Drive Innovation

globenewswire.com
AXSM BHF SCYX

PVG Sends Open Letter to Anavex Stockholders Detailing the Need for Change at the Company

globenewswire.com
AVXL AXSM MRNA

Ric Burns' Acclaimed NEW YORK: A DOCUMENTARY FILM Returns with Two New Films September 21st and 22nd On PBS

prnewswire.com
AMX GOOG CMCSA IBM MSFT NVDA INTC META AMZN NFLX ABNB UBER LYFT TSLA GM F RIVN NIO XPEV LI PLTR SNOW CRM ADBE GOOGL MSCI SPGI BKNG EXPE MAR H WYNN LVS MGM CHTR VZ T QCOM AMD MU AMAT ASML TXN NXPI ON ADI LRCX KLAC MRVL WDC SE BABA JD PDD BIDU BILI IQ VIPS HTHT NTES EDU BEKE RMAX Z HOFT PG KO PEP MCD SBUX YUM CMG WEN CAKE BJRI EAT DRI BLMN TH QSR SONO BBY WMT TGT HD LOW COST TJX ROST M KSS URBN ANF AEO LULU NKE UA CROX RL PVH TPR CPRI KHC GIS CL EL ORCL SAP ACN HPQ DELL CSCO INTU PYPL AXP V MA JPM BAC WFC C MS GS SCHW RJF LPLA BEN IVZ AB PGR ALL TRV CB UNM MET PRU AIG LNC GL CCI AMT EQIX DLR COR NTAP STX WD CDNS SNPS QTRX REGN GILD AMGN BMY ABBV LLY PFE MRK JNJ BIIB VRTX ALKS AZN SNY NVS CRSP EDIT NTLA BNTX MRNA EXAS ILMN ROKU CRWD COIN MARA RIOT FTFT BTBT CLSK HUT GLXY NNDM IONQ RIG NVCR CRBU ACRS APLS AXSM CLDX CRBP CUE CYTK DASH GRWG PLUG FCEL BE NEE DUK SO EXC SRE PCG

Axsome Therapeutics to Participate in Upcoming Investor Conferences

globenewswire.com
AXSM

Axsome Therapeutics Initiates SUMMIT Phase 3 Trial of AXS-05 in Smoking Cessation

globenewswire.com
AXSM

Dravet Syndrome Market Trends Indicate Sustained Growth During the Forecast Period (2026–2036), Driven by Novel Treatment Approaches | DelveInsight

globenewswire.com
BIIB HRMY XNCR AZN LLY PFE REGN NVS TSLA TAK GSK JNJ UCB BHF PRAX XENE AQST TNDM INCY MRK ABBV BMY AMGN GILD VRTX CRSP EDIT NTLA SRPT ALNY EXAS TEVA AXSM CYTK INSM KODK LPCN MNKD NBIX NCLH ONCY ORIC PBYI PEGA PLRX PRGS QGEN RGNX ROST RYAAY SNOW SWKS SYK TGT TRMB TXG ULTA VRSK WDC WVE XOM ZBRA ZNTL ZTS STOK IONS MOMO BBAR CTXR MBIO GNS NEON OVID BHVN

Global Neurodiagnostics Market to Accelerate Substantially at a CAGR of ~7% by 2034 | DelveInsight

globenewswire.com
ABBV AMRN AXSM BMY BIIB BSX LLY GSK JNJ MDT NVS NVO SNPS SUPN TMO ABT XOM

Postoperative Pain Management Clinical Trial Pipeline Accelerates as 45+ Pharma Companies Rigorously Developing Drugs for Market Entry | DelveInsight

globenewswire.com
VRTX VTRS HRTX AXSM

Global Neurodegenerative Disease Market is Expected to Showcase Significant Growth at a CAGR of ~6% by 2034 | DelveInsight

globenewswire.com
NVO LLY BMY AXSM JNJ SNY BIIB ABBV MRK REGN GILD AMGN AZN TEVA BHC ALKS VRTX SRPT CRIS NTLA EDIT INCY ACAD ALNY CYTK IONS EXAS IDXX VNDA SUPN RGNX XOM CVAC BNTX ARCT MRNA NBIX ADPT AVXL IMUX PRGS RDNT CRDF ADSK ANAB ATRC CLDX CPRX ESPR EXEL FGEN GALT GRFS HRMY IGC INSM KODK LAKE LCTX LEXX LPCN MESO MITK MNKD MSFT MYGN NEO NVCR NXPI OCGN OMER ORCL PACB PFE PLRX PRGO PSNL PTGX QGEN RARE ROST RVMD SEIC SIGA SMCI SNOW SOFI SPRO TGTX TNDM TXG ULTA VEEV VKTX VRNS WVE XRAY ZBRA ZNTL

Major Depressive Disorder Market is Predicted to Grow During the Forecast Period (2026-2036) as Novel Antidepressants are Expected to Enter the Market | DelveInsight

prnewswire.com
JNJ XENE LLY ABBV AXSM ALTO